Basic Information
Basic information for MIR646HG-248-34aa
Peptide Name MIR646HG-248-34aa
Genome Position chr20:60087843-60087944[+]
Species Human
Peptide Sequence MPYPAARFTRGKAEARCCILPPILPAGKLRPSAV
Peptide Length 34
Unique No (MIR646HG-202-34aa,MIR646HG-213-34aa-1,MIR646HG-218-34aa-2,MIR646HG-220-34aa,MIR646HG-221-34aa,MIR646HG-226-34aa,MIR646HG-253-34aa-2,MIR646HG-262-34aa,MIR646HG-263-34aa)
Grand Average of Hydropathicity 0.0765
Relative Molecular Mass 4246.93
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000228340;MIR646HG
Transcript ID/Name ENST00000662790;MIR646HG-248
Transcript Length 621
Coding Ability 0.2947
DNA Sequence Corresponding to Peptide ATGCCGTATCCTGCCGCCCGTTTTACCCGCGGGAAAGCCGAGGCCCGGTGCTGTATTCTGCCGCCCATTTTACCCGCGGGGAAGCTGAGGCCCAGTGCTGTT
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :